To describe nepafenac use in the Netherlands and Denmark with reference to its approved indications. For context, we also describe the use of ketorolac and diclofenac.We identified users in the PHARMO Database Network (the Netherlands, 2008-2013) and the Danish national health registers (Denmark, 1994-2014). We described prevalence of cataract surgery and duration of use in patients with cataract surgery with and without diabetes.In the Netherlands, 9530 nepafenac users (mean age, 71 years; 60
作者：Andrea V, Margulis；Eline, Houben；Jesper, Hallas；Jetty A, Overbeek；Anton, Potteg?rd；Tobias, Torp-Pedersen；Susana, Perez-Gutthann；Alejandro, Arana
来源：Acta ophthalmologica 2017 年 95卷 5期
